Key research & article

Last updated: 2025 May 18

Total hit(s): 6118

S.No.
1	40432512	Neutralizing antibody levels as a key factor in determining the immunogenic efficacy of the novel PEDV alpha coronavirus vaccine.	Vet Q	2025 Dec	8.5	1
2	40381203	Safety and immunogenicity of SARS-CoV-2 protein subunit recombinant vaccine (Indovac(R)) in healthy populations aged 18 years and above in Indonesia: A phase I, observer-blind, randomized, controlled study.	Hum Vaccin Immunother	2025 Dec	4.7	1
3	40045463	The characterization of technical design of a virus-like structure (VLS) nanodelivery system as vaccine candidate against SARS-CoV-2 variants.	Hum Vaccin Immunother	2025 Dec	4.7	1
4	39865693	Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial.	Hum Vaccin Immunother	2025 Dec	4.7	1
5	39720838	Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged >/=18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial.	Expert Rev Vaccines	2025 Dec	4.37	1
6	40371698	Natural product sennoside B disrupts liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein by inhibiting its RNA-binding activity.	J Enzyme Inhib Med Chem	2025 Dec	8.6	1
7	40077853	Characterization of the binding features between SARS-CoV-2 5'-proximal transcripts of genomic RNA and nucleocapsid proteins.	RNA Biol	2025 Dec		1
8	40329514	Integrating immune library probing with structure-based computational design to develop potent neutralizing nanobodies against emerging SARS-CoV-2 variants.	MAbs	2025 Dec	10	1
9	40366666	A four-week study on the toxicity of repeated intramuscular administration of plant-based BA-CoV2-0301 vaccine against SARS-CoV-2 in Sprague-Dawley rats.	J Immunotoxicol	2025 Dec		1
10	40529300	Delivery strategies for RNA-targeting therapeutic nucleic acids and RNA-based vaccines against respiratory RNA viruses: IAV, SARS-CoV-2, RSV.	Mol Ther Nucleic Acids	2025 Sep 9		1
11	40404003	Food-derived bioactive pigment phycocyanobilin binds to SARS-CoV-2 spike protein both covalently and noncovalently affecting its conformation and functionality.	Arch Biochem Biophys	2025 Aug		1
12	40252899	Discovery of cinnamoyl-flavonoid hybrid derivatives as inhibitors of SARS-CoV-2 M(pro) and anti-inflammatory agents: Experimental and in silico insights into their efficacy against lipopolysaccharide-induced lung injury.	Eur J Pharmacol	2025 Jul 5	3.24	1
13	40316389	Comparison of the ACE2 receptor and monoclonal antibodies immobilisation strategies for the sensitive detection of SARS-CoV-2 variants of concern.	Anal Chim Acta	2025 Jul 1	5.31	1
14	40499786	Development and Validation of Novel Cell-free Direct Neutralization Assay for SARS-CoV-2.	J Virol Methods	2025 Jun 9	1.76	1
15	40499845	Variation in anti-SARS-CoV-2 spike antibody responses by variants in patients with severe mental illness after COVID-19 vaccination.	Brain Behav Immun	2025 Jun 9	6.13	1
16	40488473	The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2.	Microbiol Spectr	2025 Jun 9	4.6	1
17	40489546	Detecting SARS-CoV-2 cryptic lineages using publicly available whole genome wastewater sequencing data.	PLoS Pathog	2025 Jun 9	6.18	1
18	40499384	A one-pot assay based on PAM-free recombinase polymerase amplification and CRISPR/Cas12a for rapid detection of SARS-CoV-2 N gene.	Talanta	2025 Jun 9	10.5	1
19	40510568	Conformational Landscaping and Dynamic Mutational Profiling of Binding Interactions and Immune Escape for Broadly Neutralizing Class I Antibodies with SARS-CoV-2 Spike Protein: Distributed Binding Hotspot Networks Underlie Mechanism of Viral Resistance Against Existing Variants.	bioRxiv	2025 Jun 9	- n/a -	1
20	40490992	An efficient strategy for producing RNA-free Nucleocapsid protein of SARS-CoV-2 for biochemical and structural investigations.	FEBS Open Bio	2025 Jun 9	2.02	1
21	40485545	Structural Analysis of the SARS-CoV-2 Spike N-Terminal Domain Across Wild-Type and Recent Variants: A Comparative Study.	Proteins	2025 Jun 9	2.499	1
22	40483559	Genetic Variations in TLR2 and TLR4 Genes and Their Association With COVID-19 Severity and Inflammatory Markers in the Moroccan Population.	Int J Immunogenet	2025 Jun 7		1
23	40483512	Histopathological examination of lung from infant with lethal COVID-19 with special attention on pneumocytes type II and the immune infiltrate: a case study.	Ital J Pediatr	2025 Jun 7	1.56	1
24	40483875	Nanobody-based fluorescent immunoassay for SARS-CoV-2 spike detection via site-specific microbial transglutaminase labeling.	Biochem Biophys Res Commun	2025 Jun 5	2.73	1
25	40465408	Therapeutic Intervention of an Intranasally Administered Monoclonal Antibody Targeting the SARS-CoV-2 Omicron Spike Protein Against SARS-CoV-2 Omicron Infection in Mice.	Viral Immunol	2025 Jun 4	3.4	1